Grants and Contributions:
Title:
Phytochemical-analog(s) as a novel method for management of treatment resistant depression - proof of concept study
Agreement Number:
982049
Agreement Value:
$75,000.00
Agreement Date:
Nov 1, 2021 - Oct 17, 2022
Description:
This project seeks to identify novel phytochemicals with higher therapeutic potential and fewer adverse effects.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Port Coquitlam, British Columbia, CA V3B 1S6
Reference Number:
172-2021-2022-Q3-982049
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
745167312
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 17 days. The total amended value is 25,000 dollars.
Amendment Date
Jan 19, 2023
Recipient's Legal Name:
MYND Life Sciences Inc.
Federal Riding Name:
Coquitlam--Port Coquitlam
Federal Riding Number:
59008
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
446199
Amendments: